[go: up one dir, main page]

HK1263136A1 - Indolinones compounds and their use in the treatment of fibrotic diseases - Google Patents

Indolinones compounds and their use in the treatment of fibrotic diseases Download PDF

Info

Publication number
HK1263136A1
HK1263136A1 HK19123146.3A HK19123146A HK1263136A1 HK 1263136 A1 HK1263136 A1 HK 1263136A1 HK 19123146 A HK19123146 A HK 19123146A HK 1263136 A1 HK1263136 A1 HK 1263136A1
Authority
HK
Hong Kong
Prior art keywords
treatment
fibrotic diseases
indolinones
compounds
indolinones compounds
Prior art date
Application number
HK19123146.3A
Other languages
Chinese (zh)
Inventor
Iain Walters
Louise BIRCH
Joseph HILL-COUSINS
Stephen Paul Collingwood
Christopher Scott STEVENSON
Original Assignee
Respivert Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Respivert Limited filed Critical Respivert Limited
Publication of HK1263136A1 publication Critical patent/HK1263136A1/en

Links

HK19123146.3A 2015-12-24 2016-12-23 Indolinones compounds and their use in the treatment of fibrotic diseases HK1263136A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15202764.5 2015-12-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK42021029292.6A Division HK40039709A (en) 2015-12-24 2019-04-30 Indolinones compounds and their use in the treatment of fibrotic diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK42021029292.6A Addition HK40039709A (en) 2015-12-24 2019-04-30 Indolinones compounds and their use in the treatment of fibrotic diseases

Publications (1)

Publication Number Publication Date
HK1263136A1 true HK1263136A1 (en) 2020-01-24

Family

ID=

Similar Documents

Publication Publication Date Title
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
EP3137116A4 (en) Dendrimer compositions and their use in treatment of diseases of the eye
ZA201804950B (en) Indolinones compounds and their use in the treatment of fibrotic diseases
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
EP3268007A4 (en) Compositions and therapeutic methods for the treatment of complement-associated diseases
EP3148526A4 (en) Use of eribulin in the treatment of cancer
EP3193875A4 (en) Levocetirizine and montelukast in the treatment of inflammation mediated conditions
EP3130582B8 (en) Compound having immune disease treatment effect and use thereof
IL249458B (en) Ppar compounds for use in the treatment of fibrotic diseases
EP3169321A4 (en) Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health
EP3194975A4 (en) Hsp90-targeted inflammation and infection imaging and therapy
EP3344632A4 (en) Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
EP3218481A4 (en) Biomarkers useful in the treatment of subjects having diseases of the eye
EP3236992A4 (en) Peptides and their use in the treatment of skin
EP3134108A4 (en) Agents and methods of treatment
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
EP3151821A4 (en) Marmelin analogs and methods of use in cancer treatment
EP3208262A4 (en) Compounds derived from 3-alkylamino-1h-indole acrylate, and the use thereof in the treatment of neurodegenerative diseases
EP3154637A4 (en) Treatment of virus-based diseases of the skin
EP3119307A4 (en) Skin treatment devices and methods
EP3226865A4 (en) Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders
HK1263136A1 (en) Indolinones compounds and their use in the treatment of fibrotic diseases
EP3209676A4 (en) Cancer and skin lesion treatment
HK1248110A1 (en) Plx-8394 or plx-7904 for use in the treatment of braf-v600-related diseases
AU2016905362A0 (en) Compounds and use thereof in methods of treatment